Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Rheumatic Heart Disease III: Medical Management

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

Rheumatic Heart Disease IV: Nursing Management

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...

Rheumatic Heart Disease I: Introduction

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.

Annals of the rheumatic diseases·2023

Same author

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries.

Annals of the rheumatic diseases·2023

Same author

Real-world data on seropositive rheumatoid arthritis, then and now: ten-year outcomes of 1151 patients diagnosed between 1997 and 2011.

Clinical and experimental rheumatology·2022

Same author

Missing data in randomised controlled trials of rheumatoid arthritis drug therapy are substantial and handled inappropriately.

RMD open·2021

Same author

Erratum to: Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study.

Rheumatology (Oxford, England)·2021

Same author

Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study.

Rheumatology (Oxford, England)·2020

Search research articles

Related Experiment Video

Updated: May 28, 2026

Treatment of Ankle Osteoarthritis with Total Ankle Replacement Through a Lateral Transfibular Approach

Treatment of Ankle Osteoarthritis with Total Ankle Replacement Through a Lateral Transfibular Approach

Published on: January 24, 2018

Declining needs for total joint replacements for rheumatoid arthritis.

Nasim A Khan, Tuulikki Sokka

Arthritis Research & Therapy

|November 2, 2011

Summary

Rheumatoid arthritis treatment advances reduce the need for joint replacement surgery. New medications and active strategies improve disease control, decreasing rates of hip and knee arthroplasty.

Area of Science:

Rheumatology
Orthopedic Surgery
Pharmacology

Background:

The advent of biologic agents has transformed rheumatoid arthritis management.
This study investigates the impact of these treatments on the incidence of total joint replacement.

Discussion:

Swedish national registry data were analyzed to compare arthroplasty rates before and after the introduction of biologic agents.
The findings suggest a significant decline in the need for hip and knee replacements.

Key Insights:

Effective rheumatoid arthritis control through advanced therapies is reducing the requirement for total joint replacement surgery.
Biologic agents play a crucial role in this paradigm shift, improving patient outcomes.

Outlook:

More Related Videos

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Related Experiment Videos

Last Updated: May 28, 2026

Treatment of Ankle Osteoarthritis with Total Ankle Replacement Through a Lateral Transfibular Approach

Treatment of Ankle Osteoarthritis with Total Ankle Replacement Through a Lateral Transfibular Approach

Published on: January 24, 2018

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Future research should focus on long-term efficacy and cost-effectiveness of biologic treatments.
Continued advancements in rheumatology promise further improvements in managing inflammatory arthritis and joint degeneration.